Angela Hall
Women's Health · Chesterfield, MONPI 1396940367
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations.
Across 131 payments — averaging $17.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$327
- Astellas Pharma US Inc$280
- Mayne Pharma Commercial LLC$252
- Exeltis, USA Inc.$173
- Therapeuticsmd, Inc.$165
- Agile Therapeutics, Inc.$150
- plus $926 from 25 others
What the payments were for
- Food & beverage$2,19997%
- Education$733%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 16 | $327 |
| Astellas Pharma US Inc | 13 | $280 |
| Mayne Pharma Commercial LLC | 17 | $252 |
| Exeltis, USA Inc. | 9 | $173 |
| Therapeuticsmd, Inc. | 14 | $165 |
| Agile Therapeutics, Inc. | 10 | $150 |
| Mylan Pharmaceuticals Inc. | 6 | $109 |
| Pfizer | 5 | $85 |
| Sumitomo Pharma America, Inc. | 4 | $78 |
| Evofem Biosciences, Inc. | 4 | $68 |
| Optumhealth Care Solutions, LLC | 4 | $62 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $58 |
| Millicent US Inc | 3 | $53 |
| Dexcom, Inc. | 2 | $47 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Biohaven Pharmaceuticals, Inc. | 2 | $38 |
| Myovant Sciences Inc. | 2 | $33 |
| Cumberland Pharmaceuticals, Inc. | 2 | $31 |
| Exact Sciences | 1 | $24 |
| Organon | 1 | $22 |
| Roche Diagnostics Corporation | 1 | $19 |
| Avion Pharmaceuticals | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Lupin Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Sage Therapeutics, LLC | 1 | $17 |
| Virtus Pharmaceuticals LLC | 1 | $16 |
| Shield Therapeutics Inc | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Lilly USA, LLC | 1 | $13 |
| Amgen | 1 | $12 |
How this compares
$2,272 in reported general payments places this provider in the 85th percentile of 208 women's health providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 34 | $2,357 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 21 | $362 |
| Oxybutynin Chloride ErOxybutynin Chloride | 11 | $246 |
| ValacyclovirValacyclovir Hcl | 11 | $223 |
Paid to pharmacies, not to this prescriber.
Other women's health in Chesterfield
- Michelle BurkChesterfield$3K
- Jesica CampbellChesterfield$2K
- Heather SiebersChesterfield$2K
- Kathryn SimoneBlue Springs$192K
- Nealya Bell-SilvaSaint Louis$107K
- Susan HoffstetterSaint Louis$39K
- Karla WilmotIndependence$22K
- Janice EislebenSaint Louis$16K
- Susan Mitchell-DerenskiSaint Louis$14K
- Amanda SchillySaint Louis$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.